← FDA Drug Approvals (Drugs@FDA)
HEMLIBRA
BLA · Biologics License Application · Sponsor: GENENTECH INC · Approved 2017-11-16
Drug application
- FDA Application #
BLA761083- Application type
- Biologics License Application
- Brand name
- HEMLIBRA
- Generic name
- EMICIZUMAB
- Active ingredients
- EMICIZUMAB
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- GENENTECH INC
- Manufacturer
- Genentech, Inc.
- First approval
- 2017-11-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown